Increasing trends of non-tuberculous mycobacteria clinical isolates in Guangzhou, China

被引:0
作者
Liu, Deqing [1 ]
Khan, Muhammad Tahir [1 ,2 ,3 ]
Tan, Yaoju [1 ]
Chen, Pingru [1 ]
Xu, Liuqing [1 ]
Liang, Feng [1 ]
Zhang, Danni [1 ]
Wei, Dongqing [4 ,5 ]
Chen, Hua [1 ]
机构
[1] Guangzhou Med Univ, Guangzhou Chest Hosp, Inst TB, Dept TB,State Key Lab Resp Dis,Guangzhou Key Lab T, Guangzhou 510095, Guangdong, Peoples R China
[2] Zhongguancun Sci Pk, Zhongjing Res & Industrializat Inst Chinese Med, Nanyang 473006, Henan, Peoples R China
[3] Univ Lahore, Inst Mol Biol & Biotechnol, KM Def Rd, Lahore 58810, Pakistan
[4] Shanghai Jiao Tong Univ, Minist Educ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol & Joint Lab Int Cooperat, 800 Dongchuan Rd, Shanghai 200240, Peoples R China
[5] 2 Peng Cheng Lab, Vanke Cloud City Phase 1 Bldg 8,Xili St, Shenzhen 518055, Guangdong, Peoples R China
关键词
Non-tuberculous mycobacteria; MAC; M; abscessus; PULMONARY; INFECTIONS; RESISTANCE;
D O I
10.1016/j.actatropica.2024.107398
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Non-tuberculous mycobacteria (NTM) are one of major public health concern. The current study aimed to find the prevalence trends of NTM in Guangzhou, China from January 2018 to December 2023. A total of 26,716 positive mycobacterial cultures were collected. Thirty-six specimens with incomplete personal information were excluded. The remaining 26,680 specimens were identified using a gene chip method. 16,709 isolates were Mycobacterium tuberculosis (MTB) (62.63 %), and 9,971 were NTM (37.37 %). 43.43 % (4,330/9,971) of NTM isolates were male, and 56.57 % (5,641/9,971) were female (chi 2 = 24.36, P < 0.05), a male to female ratio of approximately 1:1.30. Infections in individuals with aged 40 years and above was higher (77.63 %) than below 40 years (22.37 %) (chi 2 = 4.94, P = 0.026). The annual NTM isolation rates from 2018 to 2023 were 32.03 %, 34.00 %, 36.27 %, 38.58 %, 38.99 %, and 43.24 %, respectively, showing an increasing trend (chi 2 for trend = 0.097, P < 0.05) (R = 0.097, P < 0.05). Out of 9,971 NTM isolates, 8,881 cases include only five common NTM species (MAC, M. abscessus/M. chelonae, M. kansasii, M. fortuitum, and M. gordonae). The overall NTM isolation rate was 37.37 %. The NTM isolation rate was significantly higher than the national average, showing an increasing trend over the last six years.
引用
收藏
页数:6
相关论文
共 35 条
  • [1] The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases
    Baldwin, Susan L.
    Larsen, Sasha E.
    Ordway, Diane
    Cassell, Gail
    Coler, Rhea N.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (02):
  • [2] Host Resistance and Immune Aging
    Bandaranayake, Thilinie
    Shaw, Albert C.
    [J]. CLINICS IN GERIATRIC MEDICINE, 2016, 32 (03) : 415 - +
  • [3] Unveiling the Clinical Diversity in Nontuberculous Mycobacteria (NTM) Infections: A Comprehensive Review
    Bhanushali, Jay
    Jadhav, Ulhas
    Ghewade, Babaji
    Wagh, Pankaj
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [4] Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada
    Brode, Sarah K.
    Marchand-Austin, Alex
    Jamieson, Frances B.
    Marras, Theodore K.
    [J]. EMERGING INFECTIOUS DISEASES, 2017, 23 (11) : 1898 - 1901
  • [5] Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review
    Dahl, Victor Naestholt
    Molhave, Martin
    Floe, Andreas
    van Ingen, Jakko
    Schon, Thomas
    Lillebaek, Troels
    Andersen, Aase Bengaard
    Wejse, Christian
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 125 : 120 - 131
  • [6] Nontuberculous mycobacterial pulmonary disease: an integrated approach beyond antibiotics
    Faverio, Paola
    De Giacomi, Federica
    Bodini, Bruno Dino
    Stainer, Anna
    Fumagalli, Alessia
    Bini, Francesco
    Luppi, Fabrizio
    Aliberti, Stefano
    [J]. ERJ OPEN RESEARCH, 2021, 7 (02)
  • [7] Genomic characterization of Nontuberculous Mycobacteria
    Fedrizzi, Tarcisio
    Meehan, Conor J.
    Grottola, Antonella
    Giacobazzi, Elisabetta
    Serpini, Giulia Fregni
    Tagliazucchi, Sara
    Fabio, Anna
    Bettua, Clotilde
    Bertorelli, Roberto
    De Sanctis, Veronica
    Rumpianesi, Fabio
    Pecorari, Monica
    Jousson, Olivier
    Tortoli, Enrico
    Segata, Nicola
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [8] An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
    Griffith, David E.
    Aksamit, Timothy
    Brown-Elliott, Barbara A.
    Catanzaro, Antonino
    Daley, Charles
    Gordin, Fred
    Holland, Steven M.
    Horsburgh, Robert
    Huitt, Gwen
    Iademarco, Michael F.
    Iseman, Michael
    Olivier, Kenneth
    Ruoss, Stephen
    von Reyn, C. Fordham
    Wallace, Richard J., Jr.
    Winthrop, Kevin
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (04) : 367 - 416
  • [9] A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges
    Hamed, Kamal A.
    Tillotson, Glenn
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (11) : 973 - 988
  • [10] British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
    Haworth, Charles S.
    Banks, John
    Capstick, Toby
    Fisher, Andrew J.
    Gorsuch, Thomas
    Laurenson, Ian F.
    Leitch, Andrew
    Loebinger, Michael R.
    Milburn, Heather J.
    Nightingale, Mark
    Ormerod, Peter
    Shingadia, Delane
    Smith, David
    Whitehead, Nuala
    Wilson, Robert
    Floto, R. Andres
    [J]. THORAX, 2017, 72 : ii1 - ii64